SeaStar Medical Holding Corp (ICU): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex_977716.htm EXHIBIT 10.1 - 2022 OMNIBUS INCENTIVE PLAN ex_977716.htm Exhibit 10.1 SEASTAR MEDICAL HOLDING CORPORATION 2022 OMNIBUS INCENTIVE PLAN (AS AMENDED AND RESTATED EFFECTIVE JUNE 17, 2026) I PURPOSE OF THE PLAN The Plan is intended to promote the interests of t
How this was made
The 30-second read
Why it matters
This disclosure mainly updates the company’s equity compensation framework (award types, administration, and share reserve). Without additional operational or financial terms in the excerpt, it is unlikely to drive a major repricing by itself.
Market read
Compensation-plan amendments can matter for dilution/employee incentives, but the provided excerpt is largely structural and not clearly tied to a new earnings catalyst.
What to watch
Traders may want to check the full 8-K for any concurrent director/officer departures, elections, or specific award grants that could be more market-relevant than the plan text.
Background
The SEC 8-K references Item 5.02/5.07 and includes Exhibit 10.1 describing the amended and restated 2022 Omnibus Incentive Plan effective June 17, 2026.
Ticker impact
SeaStar Medical Holding Corp filed an 8-K detailing adoption of an amended 2022 Omnibus Incentive Plan effective June 17, 2026.
Low likelihood of a sustained price move solely from this disclosure; any reaction would likely be muted unless tied to concurrent exec changes or guidance (not shown here).
The provided text is incentive-plan boilerplate (award types, administration, share reserve) rather than new operating results, financing, or material litigation/contract terms.
Market effects
No clear sector read-through; this is company-specific executive compensation plan administration.
None indicated.
None indicated.
Counterpoint
If the amended plan increases share availability or changes award mix meaningfully, it could affect dilution expectations—but the excerpt does not provide enough detail to conclude that.
Key entities
- companySeaStar Medical Holding Corp
Subject issuer filing the 8-K and adopting the amended and restated 2022 Omnibus Incentive Plan effective June 17, 2026.
